UK markets closed

Remedent, Inc. (REMI)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.05500.0000 (0.00%)
At close: 01:41PM EDT

Remedent, Inc.

Zuiderlaan 1-3
Box 8
Ghent 9000
Belgium
32 9 241 58 80
https://www.remedent.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees

Key executives

NameTitlePayExercisedYear born
Mr. Guy De VreeseChairman & CEON/AN/A1955
Mr. Philippe Van AckerCFO, Chief Accounting Officer & Director188.01kN/A1965
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient's teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.

Corporate governance

Remedent, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.